Presentation TCT 2016 Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position Presenter: Niall T. Mulvihill, Antoniette Neylon October 31, 2016
Presentation TCT 2016 Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis Presenter: Niall T. Mulvihill October 31, 2016
News Daily News At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry Caitlin E. Cox October 04, 2016
News Daily News Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011 February 07, 2012